Evaluating a Behavioral Toolkit to Improve Blood Sugar and Blood Pressure in Pregnant Women With Gestational Diabetes and Hypertension

What this Trial Is About

This research aims to evaluate how a Behavioral Modification Working BMW Toolkit can improve blood sugar control and blood pressure in pregnant women diagnosed with both gestational diabetes mellitus GDM and pregnancy-induced hypertension PIH. These conditions contribute significantly to health risks for mothers and newborns, especially in low- and middle-income countries. The trial focuses on structured behavioral interventions to support lifestyle changes during pregnancy, addressing a gap in rigorously designed studies in Pakistan. Participants in this randomized controlled trial are divided into two groups. One group receives the BMW Toolkit alongside routine antenatal care, which includes 7-8 structured sessions led by a trained health educator. These sessions cover dietary changes, physical activity, sleep hygiene, and self-care during pregnancy. The other group receives only the standard antenatal care typically provided for managing GDM and PIH without the toolkit. During the study, participants will be assessed for fasting blood glucose levels at the start and at 40 weeks of pregnancy, and blood pressure readings at the start and at 36 weeks. The trial monitors these key health measures to understand the impact of the behavioral toolkit. Participation involves regular antenatal visits and adherence to the intervention sessions, with ongoing evaluation to support maternal health outcomes until delivery.

Impact of Behavioural Modification Working Toolkit Among Women With Gestational Diabetes Mellitus and Hypertension